# glp1.health Review A free GLP-1 program comparison site that tracks 50 telehealth providers weekly on price, pharmacy safety, and FDA records. ## Editor's Score: 66/100 Capability lands at 17 because the core product is a well-maintained editorial directory, not an AI tool; the matching quiz is a routing form, and no generative or predictive AI features exist, which is a real gap given the category it is filed under. Ease of use scores 21 because the site is genuinely simple: no account, no friction, a 30-second quiz, and clearly organized comparison tables. Value scores 22 because the tool is entirely free, the weekly price checks and FDA screening save real research time for cash-pay patients, and the $49/month lowest verified price data point is hard to find elsewhere without signing up to multiple programs. Delivery drops to 6 because the affiliate commission structure means every outbound link is monetized, independent verification of the no-pay-for-placement claim is not possible, and the 'AI' framing in the submission is materially misleading about what the product actually does; a tool that markets itself as AI-powered when the core function is a human-curated spreadsheet with a routing quiz has a delivery credibility problem that cannot be papered over. ## Pros - Weekly price checks at actual program checkouts catch intake fees and add-ons that headline prices hide, covering all 50 tracked programs. - Active FDA warning-letter screening removes dangerous or non-compliant programs from picks automatically; 13 programs are currently excluded on this basis. - Zero pay-for-placement policy is publicly stated and the commission disclosure is prominent, which is rare among affiliate health comparison sites. ## Cons - The 'AI' label is a stretch: the matching quiz is a simple routing tool, not a trained model, and no generative or predictive AI features are present anywhere on the site. - Affiliate commission structure means every outbound link is monetized, and while the site claims rankings are unaffected, independent verification of that claim is not possible for a visitor. - Coverage is limited to the US market and skews heavily toward compounded medication programs; patients in other countries or those seeking brand-name-only options have far fewer programs to compare (only 9 brand-name programs tracked versus 34 compounded). ## Pricing Free. - Free (all users): Free Pricing reflects what we saw at the time of review (2026-10). Confirm current pricing on the official site. Category: AI Lifestyle Tools (https://aitoolseekers.com/category/ai-lifestyle-tools) Official site: https://www.glp1.health/ Last verified by a human: 2026-10-29 Reviewed by a human at AI Tool Seekers, a hand-reviewed AI tools directory. Every listed tool is verified by a person before publishing. Scores are editorial opinions from a fixed rubric (capability, ease of use, value, delivery on promise) and cannot be bought; there is no pay-to-rank. Directory: https://aitoolseekers.com This review: https://aitoolseekers.com/tools/glp1health Methodology: https://aitoolseekers.com/how-verification-works ## Verdict glp1.health is the most methodical free resource for anyone trying to pick a GLP-1 telehealth program without getting burned by hidden fees or unvetted pharmacies. It does not use AI in any meaningful way that distinguishes it from a well-maintained spreadsheet, and its scoring methodology, while transparent, is still editorial rather than algorithmic. Anyone who already has insurance coverage and a prescriber should skip it; the site's real value is for cash-pay patients starting from scratch. Best for: Cash-pay patients comparing compounded GLP-1 programs before committing Not for: Patients with insurance coverage already working with a prescriber ## Overview glp1.health is a free comparison and safety-screening directory for online GLP-1 programs. Its core function is straightforward: it tracks 50 telehealth providers, re-checks each program's full checkout price every week, and cross-references those programs against FDA warning letters and LegitScript certification. As of the current review, 13 programs are held out of its picks because of open FDA warning letters or critical safety flags, and 36 programs are actively recommended. The site splits its coverage into two tracks: 34 cash-pay programs offering compounded semaglutide or tirzepatide (not FDA-approved, starting from $49 per month on a 12-month plan), and 9 programs prescribing brand-name FDA-approved medications like Wegovy, Zepbound, and Ozempic. A short matching quiz routes visitors to one track or the other. The site also publishes a cost calculator, a dose converter, and coverage explainers for insurance and manufacturer savings programs. The 'AI' angle here is thin. The submitted description mentions a 2-minute quiz and weekly data updates, but the site's own copy does not prominently claim AI-driven matching. The quiz is a routing tool, not a model. What glp1.health actually offers is disciplined, human-curated editorial work: weekly price checks at real checkouts, a stated zero-pay-for-placement policy, and a public methodology for its 10-point scores. That is genuinely useful, but buyers expecting generative AI features will not find them here. ## Who should use it The clearest fit is someone who has decided to try a GLP-1 medication, plans to pay out of pocket, and does not yet know which telehealth program to trust. The site's weekly price checks and FDA-flag screening do real work for that person: the cheapest verified program on a 12-month plan starts at $49 per month, and knowing which of the 50 tracked programs currently carries an open FDA warning letter is genuinely hard to find elsewhere for free. Anyone already enrolled in a program, covered by insurance with an established prescriber, or looking for clinical guidance rather than a price comparison should look elsewhere. For general health habit tracking and AI-driven lifestyle coaching, ChromaSeason or PawCoach serve very different needs, but within the health-decision space, a patient with insurance should go directly to their insurer's telehealth portal rather than a cash-pay comparison tool. ## FAQ Q: Is glp1.health actually free to use? A: Yes. There are no paid tiers, no account required, and no paywalled features. The site earns affiliate commissions when visitors click through to a program and sign up, but all comparison data, scores, and tools are free. Q: How many GLP-1 programs does the site track? A: 50 programs total. Of those, 36 are currently recommended and 13 are excluded because of open FDA warning letters or critical safety flags. The site covers 34 cash-pay compounded programs and 9 brand-name programs. Q: What is the cheapest program the site has verified? A: The lowest verified price is $49 per month, available on a 12-month prepaid plan for compounded semaglutide or tirzepatide. The lowest month-to-month price across tracked programs is $76. Q: Does the site sell or prescribe medication? A: No. glp1.health is a comparison and information resource only. It links to telehealth programs that prescribe and dispense medication, but does not itself prescribe, dispense, or handle any medication. Q: Can a program pay to rank higher on the site? A: The site states explicitly that programs cannot pay for a higher score or a better placement. It discloses that linked programs pay an affiliate commission, but says commission does not affect rankings. Q: Does the site cover insurance-based GLP-1 programs? A: Yes, but with limited depth. Nine programs that prescribe brand-name FDA-approved medications (Wegovy, Zepbound, Ozempic) are tracked, along with guides on using insurance and manufacturer savings programs. The bulk of the site's coverage focuses on cash-pay compounded options.